Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.94x is 97% above its 5-year average of -116.17x, near the high end of its 5-year range (-844.50x–18.64x).
As of the fiscal period ended Tuesday, June 30, 2026. 153.56% below its 12-month average of 7.35x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.94x.
INTEREST COVERAGE RATIO
-3.94x
INTEREST COVERAGE RATIO AVG TTM
7.35x
INTEREST COVERAGE RATIO AVG 3Y
-233.23x
INTEREST COVERAGE RATIO AVG 5Y
-116.17x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-153.56%
CURRENT VS 3Y AVG
+98.31%
CURRENT VS 5Y AVG
+96.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+38.25%
vs the sector median at left
Tenon Medical, Inc.
Market Cap
$1.89M
Interest Coverage Ratio
-3.94x
TTM Avg
7.35x
3Y Avg
-233.23x
5Y Avg
-116.17x
Market Cap
$1.89M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86M
Interest Coverage Ratio
-2.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.83M
Interest Coverage Ratio
-4229.15x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65M
Interest Coverage Ratio
-114.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenon Medical, Inc. (TNON) | $1.89M | -3.94x | 7.35x | -233.23x | -116.17x |
| Beyond Air, Inc. (XAIR)vs › | $1.89M | N/A | N/A | N/A | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.89M | N/A | N/A | N/A | N/A |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.86M | -2.60x | N/A | N/A | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.83M | -4229.15x | N/A | N/A | N/A |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.80M | N/A | N/A | N/A | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.11M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.11M | N/A | N/A | N/A | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | -114.76x | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.51M | -37.39x | N/A | N/A | N/A |
Interest Coverage
-3.9x
Debt/Equity
N/A
Current Ratio
0.58
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.94x |
| 2026-03-31 | 18.64x |
| 2024-03-31 | -103.12x |
| 2023-09-30 | -844.50x |
| 2022-06-30 | -62.00x |
| 2022-03-31 | -7.59x |
| 2021-12-31 | -9.12x |
| 2021-09-30 | -7.85x |
| 2021-06-30 | -26.02x |
| 2021-03-31 | -17.18x |
